Acta2-CreERT2

品系全名

C57BL/6Smoc-Acta2em1(CreERT2-Wpre-polyA)Smoc

目录号

NM-KI-200074

品系状态

活体

导出PDF

基因信息

基因名
Acta2

品系描述

将CreERT2-Wpre-polyA插入到小鼠Acta2基因起始密码子处。
应用领域:该小鼠在Acta2基因座表达 CreERT2 重组酶。可用于研究组织平滑肌的功能。

验证数据

NM-KI-200074;Acta2-CreERT2-1.png

图 1 Acta2CreERT2/+; Rosa26tdTomato/+ 小鼠胰腺中tdTomato的表达情况。

经Tamoxifen诱导后, Acta2CreERT2/+; Rosa26tdTomato/+ 双转基因鼠,可在小鼠胰腺部位的血管平滑肌细胞中检测到tdTomato的表达。未经Tamoxifen处理时,可见tdTomato漏表达。

NM-KI-200074;Acta2-CreERT2-2.png

图 2 Acta2CreERT2/+; Rosa26tdTomato/+ 小鼠各组织中tdTomato的表达情况。TdTomato的表达可在胰腺、肾脏、脑、心脏、肺、肝、颌下腺、棕色脂肪、卵巢、肌肉、胸腺、脾脏、大肠和小肠中检测到,而垂体中检测不到。在Tamoxifen诱导前,有漏表达。(更多详细信息请联系我司技术顾问。)


你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看